apl. Prof. Dr. Antoniu-Oreste Gostian

Medizinische Fakultät Department of Otorhinolaryngology – Head and Neck Surgery (HNO-Klinik)

Reduction of elective radiotherapy treatment volume in definitive treatment of locally advanced head and neck cancer—comparison of a prospective trial with a revised simulated contouring approach (2021) Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M, Semrau S, et al. Journal article Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells (2021) Wimmer S, Deloch L, Hader M, Derer A, Grottker F, Weissmann T, Hecht M, et al. Journal article Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study (2021) Sievert M, Goncalves M, Binder B, Müller SK, Rupp R, Koch M, Dürr S, et al. Journal article Therapies for synchronous malignomas - the importance of interdisciplinary oncology (2021) Müller SK, Haderlein M, Traxdorf M, Semrau S, Agaimy A, Lettmaier S, Gostian AO, et al. Journal article, Editorial Histopathology of Parotid Pleomorphic Adenomas: A "Pleomorphic Approach" to a Demanding Lesion (2021) Mantsopoulos K, Thimsen V, Gostian AO, Müller SK, Sievert M, Iro AK, Agaimy A, Iro H Journal article Precautionary documents in patients with head and neck cancer - status quo and factors influencing their creation (2021) Allner M, Gostian M, Balk M, Rupp R, Hecht M, Ostgathe C, Müller SK, et al. Conference contribution Time dependency of adjuvant therapy in advanced head-and-necksquamous-cell-carcinoma of unknown primary (CUP)-patients (2021) Balk M, Rupp R, Grundtner P, Müller SK, Allner M, Traxdorf M, Eckstein M, et al. Conference contribution Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration (2021) Hecht M, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Klautke G, Laban S, et al. Conference contribution Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution